Amended Advisors Agreement with The Sage Group, Inc. dated July 15 2010 AMENDED ADVISER’S AGREEMENTAdvisers Agreement • August 6th, 2010 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Pennsylvania
This Amended Advisers Agreement (the "Agreement") is entered into as of July 15, 2010 by and between HemispherX BioPharma, Inc., a Delaware Corporation ("Company"), and The Sage Group, Inc. and its employees, Principals, and Senior Directors (“Adviser”), a New Jersey corporation, with respect to the following:
EXHIBIT A – Adviser’s Agreement and Fee WaiverAdviser's Agreement • March 18th, 2014 • Valley Forge Fund Inc
The above-named registered investment company (the "Fund") herewith confirms its agreement with Boyle Capital Management, LLC (referred to herein for convenience as “you”) as follows:
SECOND AMENDED AND RESTATED ADVISER’S AGREEMENTAdviser’s Agreement • March 14th, 2012 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Pennsylvania
This Amended Advisers Agreement (the "Agreement") is entered into as of June 15, 2011 (the “Effective Date”) by and between Hemispherx BioPharma, Inc., a Delaware corporation ("Company"), and The Sage Group, Inc. and its employees, Principals, and Senior Directors (“Adviser”), a New Jersey corporation, and amends and restates in its entirety the Adviser’s Agreement between the parties dated October 2, 2008, as amended on July 15, 2010, and the Master Agreement dated March 31, 2009, with respect to the following:
